Healthcare -
Biotechnology - NASDAQ - US
$ 108.9718
0.112 %
$ 5.28 B
Market Cap
-16.56
P/E
AXSM - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities AXSM - Axsome Therapeutics, Inc.
331 M
LAST VALUE
445.36%
2 YEAR CAGR
101.22%
5 YEAR CAGR
56.66%
10 YEAR CAGR